Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 152, Issue 1, 1995, Pages 45-52

  Booth, Helen ^b   Richmond, Ian ^b   Ward, Chris ^b   Gardiner, Philip V ^b   Harkawat, Rita ^b   Walters, E Haydn ^a  

^a ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE;

ADULT; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS REACTIVITY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; LUNG LAVAGE; MALE; MAST CELL; PRIORITY JOURNAL; STEROID THERAPY; TARGET CELL;

EID: 0029090365     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.152.1.7599861     Document Type: Article

References (35)

1. Djukanovic, R., W. R. Roche, J. W. Wilson, C. R. W. Beasley, O. P. Twentyman, P. H. Howarth, and S. T. Holgate. 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:434-457.
2. British Thoracic Society. 1993. Guidelines for treatment of asthma. Thorax 48:S1-S24.
3. Barnes, P. J., and S. Pederson. 1993. Efficacy and safety of inhaled corticosteroids in asthma. Am. Rev. Respir. Dis. 148:S1-S26.
4. Djukanovic, R. D., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1992. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 145:669-674.
5. Jeffery, P. K., R. W. Godfrey, E. Adelroth, F. Nelson, A. Rogers, and S.-A. Johansson. 1992. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am. Rev. Respir. Dis. 145:890-899.
6. Smith, D. L., and R. D. Deshazo. 1993. Bronchoalveolar lavage in asthma. An update and perspective. Am. Rev. Respir. Dis. 148: 523-532.
7. Adelroth, E., L. Rosenhall, S.-A. Johansson, M. Linden, and P. Venge. 1990. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am. Rev. Respir. Dis. 142:91-99.
8. Duddridge, M., C. Ward, D. J. Hendrick, and E. H. Walters. 1993. Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients with high dose inhaled beclomethasone dipropionate. Eur. Respir. J. 6: 489-497.
9. Phillipps, G. H. 1990. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir. Med. 84:S19-S23.
10. Barnes, N. C., G. Marone, G. U. Di Maria, S. Visser, I. Utama, and S. L. Payne. 1993. A comparison of fluticasone propionate, 1 mg daily with beclomethasone dipropionate, 2 mg daily in the treatment of severe asthma. Eur. Respir. J. 6:877-884.
11. American Thoracic Society. 1987. Guidelines for the diagnosis and treatment of patients with chronic pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
12. Burrows, B., F. D. Martinez, M. Halonen, R. A. Barbee, and M. G. Cline. 1989. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 320:271-277
13. Beach, J. R., C. L. Young, A. J. Avery, S. C. Stenton, J. H. Dennis, E. H. Walters, and D. J. Hendrick. 1993. Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax 48:239-243.
14. Dennis, J. H., S. C. Stenton, J. R. Beach, A. J. Avery, E. H. Walters, and D. J. Hendrick. 1990. Jet and ultrasonic nebulizer output: use of a new method for direct measurement of aerosol output. Thorax 45:728-732.
15. Laviolette, M., M. Carreaux, and R. Coulombe. 1988. Bronchoalveolar lavage cell differential on microscope glass cover. Am. Rev. Respir. Dis. 138:451-457.
16. Walls, A. F., A. R. Bennet, H. M. McBride, M. J. Glennie, S. T. Holgate, and M. K. Church. 1990. Production and characterisation of monoclonal antibodies specific for human mast cell tryptase. Clin. Exp. Allergy. 20:581-589.
17. Jenkins, C. R., and A. J. Woolcock. 1988. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax 43:378-384.
18. Kraan, J., G. H. Koeter, T. W. van der Mark, M. Boorsma, J. Kukler, H. J. Sluiter, and K. de Vries. 1988. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:44-48.
19. Vathenan, A. S., A. J. Knox, A. Wisniewski, and A. E. Tattersfield. 1991. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am. Rev. Respir. Dis. 143:1317-1321.
20. Juniper, E. F., P. A. Kline, M. A. Vanzieleghem, E. H. Ramsdale, P. M. O'Byrne, and F. E. Hargreave. 1990. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non-steroid-dependent asthmatics. Am. Rev. Respir. Dis. 142:832-836.
21. Fabbri, L., P. S. Burge, L. Croonenborgh, F. Warlies, B. Weeke, A. Ciaccia, and C. Parker. 1993. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate severe asthma treated for one year. Thorax 48:817-823.
22. Wilson, J. W., R. Djukanovic, P. H. Howarth, and S. T. Holgate. 1992. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am. Rev. Respir. Dis. 145:958-960.
23. Wardlaw, A. J., S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
24. Bousquet, J., P. Chanez, J. Y. Lacoste, I. Enander, P. Venge, C. Peterson, S. Ahlstedt, F.-B. Michel, and P. Godard. 1991. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J. Allergy Clin. Immunol. 88:649-660.
25. Gonzales, M. C., P. Diaz, F. R. Galleguillos, P. Ancic, O. Cromwell, and A. B. Kay. 1987. Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 in single early responders compared with those in late-phase responders. Am. Rev. Respir. Dis. 136:600-604.
26. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blase, and J.-C. Virchow. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
27. Bentley, A. M., G. Menz, C. Storz, D. S. Robinson, B. Bradley, P. K. Jeffrey, S. R. Durham, and A. B. Kay. 1992. Identification of T-lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am. Rev. Respir. Dis. 146:500-506.
28. Wenzel, S. E., A. A. Fowler, and L. B. Schwartz. 1988. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am. Rev. Respir. Dis. 137:1002-1008.
29. Wong, B. J., J. Dolovich, H. Ramsdale, P. O'Bryne, L. Gontovnick, J. A. Denburg, and F. E. Hargreave. 1992. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Am. Rev. Respir. Dis. 146:1156-1160.
30. Moqbel, R., J. Barkans, B. L. Bradley, S. R. Durham, and A. B. Kay. 1992. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin. Exp. Allergy 22:265-273.
31. Lozewicz, S., J. Wang, J. Duddle, K. Thomas, S. Chalstrey, G. Reilly, J. L. Devalia, and R. J. Davies. 1992. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J. Allergy Clin. Immunol. 89:951-957.
32. Lundgren, R., M. Soderberg, P. Horstedt, and R. Stenling. 1988. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur. Respir. J. 1:883-889.
33. Geddes, D. M. 1992. Inhaled corticosteroids: benefits and risks. Thorax 47:404-407.
34. Cohan, V. L., B. J. Undem, C. C. Fox, N. F. Adkinson, L. M. Lichtenstein, and R. P. Schleimer. 1989. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am. Rev. Respir. Dis. 140:951-954.
35. Cockcroft, D. W., and K. Y. Murdock. 1987. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, and increased bronchial responsiveness to histamine. J. Allergy Clin. Immunol. 79:734-740.